Correlation Between Inhibrx and Joint Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Joint Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Joint Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and The Joint Corp, you can compare the effects of market volatilities on Inhibrx and Joint Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Joint Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Joint Corp.

Diversification Opportunities for Inhibrx and Joint Corp

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Inhibrx and Joint is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and The Joint Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Joint Corp and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Joint Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Joint Corp has no effect on the direction of Inhibrx i.e., Inhibrx and Joint Corp go up and down completely randomly.

Pair Corralation between Inhibrx and Joint Corp

Given the investment horizon of 90 days Inhibrx is expected to generate 8.3 times less return on investment than Joint Corp. In addition to that, Inhibrx is 1.01 times more volatile than The Joint Corp. It trades about 0.0 of its total potential returns per unit of risk. The Joint Corp is currently generating about 0.02 per unit of volatility. If you would invest  1,144  in The Joint Corp on August 30, 2024 and sell it today you would earn a total of  6.00  from holding The Joint Corp or generate 0.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy97.73%
ValuesDaily Returns

Inhibrx  vs.  The Joint Corp

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Inhibrx are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Inhibrx may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Joint Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in The Joint Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Joint Corp is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Inhibrx and Joint Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Joint Corp

The main advantage of trading using opposite Inhibrx and Joint Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Joint Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Joint Corp will offset losses from the drop in Joint Corp's long position.
The idea behind Inhibrx and The Joint Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges